These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 15066747)
1. Meningitis with multidrug-resistant Acinetobacter baumannii treated with ampicillin/sulbactam. Kendirli T; Aydín HI; Hacíhamdioğlu D; Gülgün M; Unay B; Akín R; Lenk MK; Gökçay E J Hosp Infect; 2004 Apr; 56(4):328. PubMed ID: 15066747 [No Abstract] [Full Text] [Related]
2. [Successful treatment of a patient with multidrug resistant Acinetobacter baumannii meningitis with high dose ampicillin-sulbactam]. Sayin Kutlu S; Saçar S; Süzer T; Cevahir N; Okke D; Dirgen Caylak S; Turgut H Mikrobiyol Bul; 2008 Apr; 42(2):353-8. PubMed ID: 18697435 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia. Betrosian AP; Frantzeskaki F; Xanthaki A; Douzinas EE J Infect; 2008 Jun; 56(6):432-6. PubMed ID: 18501431 [TBL] [Abstract][Full Text] [Related]
4. Successful treatment of multidrug-resistant Sun L; Wang X; Li Z Br J Neurosurg; 2018 Dec; 32(6):642-645. PubMed ID: 28431478 [No Abstract] [Full Text] [Related]
5. Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments. Rodríguez Guardado A; Blanco A; Asensi V; Pérez F; Rial JC; Pintado V; Bustillo E; Lantero M; Tenza E; Alvarez M; Maradona JA; Cartón JA J Antimicrob Chemother; 2008 Apr; 61(4):908-13. PubMed ID: 18281693 [TBL] [Abstract][Full Text] [Related]
6. Combination carbapenem-sulbactam therapy for critically ill patients with multidrug-resistant Acinetobacter baumannii bacteremia: four case reports and an in vitro combination synergy study. Lee NY; Wang CL; Chuang YC; Yu WL; Lee HC; Chang CM; Wang LR; Ko WC Pharmacotherapy; 2007 Nov; 27(11):1506-11. PubMed ID: 17963460 [TBL] [Abstract][Full Text] [Related]
7. In vitro pharmacodynamics of human-simulated exposures of ampicillin/sulbactam, doripenem and tigecycline alone and in combination against multidrug-resistant Acinetobacter baumannii. Housman ST; Hagihara M; Nicolau DP; Kuti JL J Antimicrob Chemother; 2013 Oct; 68(10):2296-304. PubMed ID: 23710070 [TBL] [Abstract][Full Text] [Related]
8. Multidrug-resistant Acinetobacter infections: an emerging challenge to clinicians. Jain R; Danziger LH Ann Pharmacother; 2004 Sep; 38(9):1449-59. PubMed ID: 15280512 [TBL] [Abstract][Full Text] [Related]
9. Successful treatment of multidrug resistant Acinetobacter baumannii meningitis. Saçar S; Turgut H; Cenger DH; Coşkun E; Asan A; Kaleli I J Infect Dev Ctries; 2007 Dec; 1(3):342-4. PubMed ID: 19734617 [TBL] [Abstract][Full Text] [Related]
10. Prevention of rifampicin resistance in Acinetobacter baumannii in an experimental pneumonia murine model, using rifampicin associated with imipenem or sulbactam. Pachón-Ibáñez ME; Fernández-Cuenca F; Docobo-Pérez F; Pachón J; Pascual A J Antimicrob Chemother; 2006 Sep; 58(3):689-92. PubMed ID: 16870647 [TBL] [Abstract][Full Text] [Related]
11. Successful treatment of skin and soft tissue infection due to carbapenem-resistant Acinetobacter baumannii by ampicillin-sulbactam and meropenem combination therapy. Hiraki Y; Yoshida M; Masuda Y; Inoue D; Tsuji Y; Kamimura H; Karube Y; Takaki K; Kawano F Int J Infect Dis; 2013 Dec; 17(12):e1234-6. PubMed ID: 23791858 [TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo activity of meropenem and sulbactam against a multidrug-resistant Acinetobacter baumannii strain. Ko WC; Lee HC; Chiang SR; Yan JJ; Wu JJ; Lu CL; Chuang YC J Antimicrob Chemother; 2004 Feb; 53(2):393-5. PubMed ID: 14729739 [TBL] [Abstract][Full Text] [Related]
13. Trends in antimicrobial resistance of Acinetobacter baumannii isolates from a metropolitan Detroit health system. Reddy T; Chopra T; Marchaim D; Pogue JM; Alangaden G; Salimnia H; Boikov D; Navon-Venezia S; Akins R; Selman P; Dhar S; Kaye KS Antimicrob Agents Chemother; 2010 May; 54(5):2235-8. PubMed ID: 20211887 [TBL] [Abstract][Full Text] [Related]
14. Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii. Urban C; Segal-Maurer S; Rahal JJ Clin Infect Dis; 2003 May; 36(10):1268-74. PubMed ID: 12746772 [TBL] [Abstract][Full Text] [Related]
15. Comparative activities of colistin, rifampicin, imipenem and sulbactam/ampicillin alone or in combination against epidemic multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 carbapenemases. Tripodi MF; Durante-Mangoni E; Fortunato R; Utili R; Zarrilli R Int J Antimicrob Agents; 2007 Dec; 30(6):537-40. PubMed ID: 17851050 [TBL] [Abstract][Full Text] [Related]
16. Tigecycline use in two cases with multidrug-resistant Acinetobacter baumannii meningitis. Tutuncu EE; Kuscu F; Gurbuz Y; Ozturk B; Haykir A; Sencan I Int J Infect Dis; 2010 Sep; 14 Suppl 3():e224-6. PubMed ID: 19962335 [TBL] [Abstract][Full Text] [Related]
17. Molecular findings and antibiotic-resistance in an outbreak of Acinetobacter baumannii in an intensive care unit. Longo B; Pantosti A; Luzzi I; Tarasi A; Di Sora F; Gallo S; Placanica P; Monaco M; Dionisi AM; Volpe I; Montella F; Cassone A; Rezza G Ann Ist Super Sanita; 2007; 43(1):83-8. PubMed ID: 17536158 [TBL] [Abstract][Full Text] [Related]
18. Successful treatment of multidrug-resistant Acinetobacter baumannii central nervous system infections with colistin. Katragkou A; Roilides E J Clin Microbiol; 2005 Sep; 43(9):4916-7. PubMed ID: 16145177 [No Abstract] [Full Text] [Related]